Loading

Immunization Information

All information about Immunization, Immunization Latest News

Kissin Memo: Piecing Together the Anthrax Letters Story

The Frederick News-Post has posted a long memorandum by Attorney Barry Kissin , a resident of Frederick, Maryland on its website. Attorney Kissin has no professional connection to USAMRIID or Dr. Ivins. Yet he has followed the anthrax letters story closely, and has written a cogent and thoroughly documented though…

FBI and Sandia were unable to produce an identical spore preparation: so how could they prove Ivins made the spores on Fort Detrick equipment??

Audio and Text from the National Academy of Engineering Anthrax Close-up, Part 2 12/14/2008 The FBI says spores from the anthrax attack letters are genetically linked to spores in a flask controlled by Fort Detrick researcher Bruce Ivins. But high-tech microscopic analysis shows what might be a key difference….

No reason to assume the anthrax powder was produced in the week before the letters were sent/ GSN

From Global Security Newswire , including material from the Frederick News-Post: The fact that Ivins kept very late laboratory hours in the days before the letters were mailed is not as unusual as the FBI contends, said former USAMRIID head of bacteriology Gerry Andrews. Ivins was working on multiple…

Additional details emerge to challenge the FBI’s anthrax letter scenario

Today’s NY Times carries an article by Richard Bernstein, ” Haste Leaves Anthrax Case Unconcluded.” Edited only slightly for brevity, the article follows: … an article in Aerosol Science and Technology published in March 2008 has acquired considerable significance in light of the announcement by the F.B.I. last week…

Novartis receives FDA approval of Menveo®

Novartis announced that Menveo®, a quadrivalent meningococcal conjugate vaccine was approved by the US Food and Drug Administration (FDA) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people 11 to 55 years of age[1].

Original Source of Novartis receives…

US FDA approves Rituxan/MabThera for the most common type of adult leukemia

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) approved Rituxan/MabThera (rituximab) plus fludarabine and cyclophosphamide (FC) chemotherapy for people with either previously untreated (first-line) or previously treated (relapsed or refractory) CD20-positive chronic lymphocytic leukemia (CLL).

Original Source of US FDA approves Rituxan/MabThera for…

FBI: CASE CLOSED (and Ivins did it)

But FBI’s report was released on Friday afternoon… which means the FBI anticipated doubt and ridicule. And the National Academy of Science (NAS) is several months away from issuing its report on the microbial forensics, suggesting a) asking NAS to investigate the FBI’s science was just a charade to placate…

England drowning in swine flu vaccine; Poland has none and explains why/ BBC

From Fergus Walsh, BBC Medical correspondent: By my reckoning (and this is an estimate only) around 5.25 million people have been vaccinated in Britain. That means there is an awful lot of vaccine – tens of millions of doses – going spare. I’m told an announcement is likely in around…

Another Attempt to Delay Release of David Kelly’s Autopsy Records/ Daily Mail

In January, the Daily Mail revealed that Lord Hutton ordered David Kelly’s post-mortem records to be barred from public access for 70 years. Hutton then responded that he would make the records available to physicians conducting a public inquiry on the death. Instead, the UK’s Ministry of Justice said the…

CDC paid Harvard School Public Health for Multiple Polls of swine flu uptake, though it already knew the answer/ CDC

After many polls of how many people got vaccinated, you can see that all were an unnecessary waste of taxpayer dollars by CDC, here : The National Pandemic Influenza Plan calls for the Department of Health and Human Services (HHS) agencies, specifically the Centers for Disease Control and Prevention…